Real-world effectiveness of repeated ketamine infusions for treatment resistant depression during the COVID-19 pandemic

Herein we evaluate the impact of COVID-19 restrictions on antidepressant effectiveness of intravenous (IV) ketamine in adults with treatment-resistant depression (TRD). We conducted a case series analysis of adults with TRD (n = 267) who received four ketamine infusions at an outpatient clinic in On...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenblat, Joshua D., Lipsitz, Orly, Di Vincenzo, Joshua D., Rodrigues, Nelson B., Kratiuk, Kevin, Subramaniapillai, Mehala, Lee, Yena, Arekapudi, Anil K., Abrishami, Amir, Chau, Edmond H., Szpejda, Witold, Wong, Leslie, Mansur, Rodrigo B., McIntyre, Roger S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240444/
https://www.ncbi.nlm.nih.gov/pubmed/34246008
http://dx.doi.org/10.1016/j.psychres.2021.114086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240444/
https://www.ncbi.nlm.nih.gov/pubmed/34246008
http://dx.doi.org/10.1016/j.psychres.2021.114086

Ejemplares similares